Search Results - "Janatová, Anežka"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases by Skala, Tomáš, Kahánková, Zdeˇnka, Tauchen, Jan, Janatová, Anežka, Klouˇcek, Pavel, Hubka, Vít, Fraˇnková, Adéla

    Published in Frontiers in microbiology (20-09-2022)
    “…Cannabis preparations are gaining popularity among patients with various skin diseases. Due to the lack of scientific evidence, dermatologists remain cautious…”
    Get full text
    Journal Article
  2. 2

    Amino Acid Supplementation as a Biostimulant in Medical Cannabis ( Cannabis sativa L.) Plant Nutrition by Malík, Matěj, Velechovský, Jiří, Praus, Lukáš, Janatová, Anežka, Kahánková, Zdeňka, Klouček, Pavel, Tlustoš, Pavel

    Published in Frontiers in plant science (31-03-2022)
    “…There is growing evidence to support the involvement of nutrients and biostimulants in plant secondary metabolism. Therefore, this study evaluated the…”
    Get full text
    Journal Article
  3. 3

    Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing by Kaczorová, Dominika, Peč, Jaroslav, Béres, Tibor, Štefelová, Nikola, Ćavar Zeljković, Sanja, Trojan, Václav, Janatová, Anežka Kosmáková, Klouček, Pavel, Tarkowski, Petr

    Published in Frontiers in pharmacology (01-08-2023)
    “…Although medical cannabis was legalized in Czechia in 2013 and its use in topical treatments of skin disorders is now allowed, galenic formulations prepared…”
    Get full text
    Journal Article
  4. 4

    The chemical composition of ethanolic extracts from six genotypes of medical cannabis (Cannabis sativa L.) and their selective cytotoxic activity by Janatová, Anežka, Doskočil, Ivo, Božik, Matěj, Fraňková, Adéla, Tlustoš, Pavel, Klouček, Pavel

    Published in Chemico-biological interactions (01-02-2022)
    “…Cannabis (Cannabis sativa L.) for medical purposes has been legalized again in many countries in recent years. Currently, only two major cannabinoids (Δ9-THC…”
    Get full text
    Journal Article
  5. 5

    Yield and cannabinoids contents in different cannabis (Cannabis sativa L.) genotypes for medical use by Janatová, Anežka, Fraňková, Adéla, Tlustoš, Pavel, Hamouz, Karel, Božik, Matěj, Klouček, Pavel

    Published in Industrial crops and products (01-02-2018)
    “…•Seven cannabis genotypes were cultivated over six consecutive cycles.•The inflorescence yields among genotypes ranged from 15.41 to 24.74g/plant.•The content…”
    Get full text
    Journal Article
  6. 6

    Long-term antifungal activity of volatile essential oil components released from mesoporous silica materials by Janatova, Anezka, Bernardos, Andrea, Smid, Jakub, Frankova, Adela, Lhotka, Miloslav, Kourimská, Lenka, Pulkrabek, Josef, Kloucek, Pavel

    Published in Industrial crops and products (01-05-2015)
    “…[Display omitted] •Encapsulated and pure compounds were tested against Aspergillus niger.•Encapsulation into silica was superior to pure compounds.•Thymol,…”
    Get full text
    Journal Article